ADM2 and thyroid gland carcinoma: For Adm2, IHC studies confirmed the reduced expression in the PVPV-Akt KO mouse thyroids and an increase in expression with invasion in human thyroid cancer, consistent with potential regulation by Akt signaling (Supplemental Fig. 3).